ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

Technology provides groundbreaking planning and guidance capabilities

Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230524005371/en/

Stryker's Q Guidance System with Cranial Guidance Software provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries. (Photo: Business Wire)

Stryker's Q Guidance System with Cranial Guidance Software provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries. (Photo: Business Wire)

"In my opinion, Stryker's Q Guidance System with Cranial Guidance Software could be the new gold standard for image-guided neurosurgical navigation," said Dr. Melvin Field, medical director for the Minimally Invasive Brain Surgery program at AdventHealth, and member of Orlando Neurosurgery, one of the first surgeons to bring the system to his OR. "Cranial procedures are extremely delicate, and outcomes may go beyond physical health, potentially altering your patient's appearance or personality. The system offers advanced planning and guidance capabilities, giving me greater confidence to perform these complex surgeries."

Leading up to a full commercial launch, Stryker’s Q Guidance System with Cranial Guidance Software will be utilized at five additional EPS sites: the University of New Mexico, the University of Arkansas, the University of Michigan, Thomas Jefferson University, and Lenox Hill Hospital.

Cranial Guidance Software provides a single solution to track brain biopsy and shunt placement instruments, and includes automatic, algorithmic processing as well as comprehensive segmentation capabilities. The software provides tools enabled by gesture recognition for identifying, marking, and localizing targets and anatomical structures of interest.

Learn more about this new technology at strykeronegiantleap.com.

* Dr. Melvin Field is a paid consultant of Stryker. His statements represent his own opinions based on personal experience and are not necessarily those of Stryker. Individual results may vary.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.

More information is available at www.stryker.com.

Content ID: QGS-PR-6_34619

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.